This is a post - market study with a wound dressing, a CE-marked medical device available on the european market. The device will be used in routine clinical practice, i.e. within its intended purpose and without any additional invasive or stressing examinations for the patients. Up to 36 adult patients with wounds suitable to be treated with the medical device and meeting the inclusion/exclusion criteria will be enrolled at two participating German sites. During 5 on-site visits within 28 days routine weekly dressing changes the Health Care Professional will examine the wound and will perform required wound care and dressing changes. Pictures of the wound with and without dressing will be taken at each visit and used for automatic analysis. The subjects will be asked to rate their general wound pain and the pain perceived during dressing changes. A wound-related quality of life questionnaire will be presented to the subjects twice and the subject and HCP will rate their safisfaction with the product.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Exudate absorption by IMD ('yes', 'no')
Timeframe: day 7
Exudate absorption by IMD ('yes', 'no')
Timeframe: day 14
Exudate absorption by IMD ('yes', 'no')
Timeframe: day 21
Exudate absorption by IMD ('yes', 'no')
Timeframe: day 28
Exudate accumulation in the wound by IMD ( 'no', 'minimal amount', 'medium amount', 'high amount')
Timeframe: day 7
Exudate accumulation in the wound by IMD ( 'no', 'minimal amount', 'medium amount', 'high amount')
Timeframe: day 14
Exudate accumulation in the wound by IMD ( 'no', 'minimal amount', 'medium amount', 'high amount')
Timeframe: day 21
Exudate accumulation in the wound by IMD ( 'no', 'minimal amount', 'medium amount', 'high amount')
Timeframe: day 28